Vitrectomy for Branch Retinal Vein Occlusion
- Conditions
- Vitrectomy
- Registration Number
- NCT00685490
- Lead Sponsor
- Shinjo Ophthalmologic Institute
- Brief Summary
To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occlusion (BRVO).
Results suggest the following hypothesis:
* PPV, with and without ILM peeling, appears to be beneficial in eyes with persistent macular edema due to BRVO
* Effectiveness is maintained long term
* ILM peeling does not significantly affect postoperative best corrected visual acuity (BCVA)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- duration of symptoms lasting 27 weeks
- vitreous hemorrhage
- severe cataract
- biomicroscopic vitreomacular traction and epiretinal membrane
- previous vitreoretinal surgery
- other ocular diseases that could contribute to visual loss.
- patients with macular branch vein occlusion
- patients with a history of previous grid laser photocoagulation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reporting of the long term outcomes of PPV, with and without ILM peeling, in eyes with persistent macular edema secondary to BRVO 11 years
- Secondary Outcome Measures
Name Time Method Elevate the effectiveness of ILM peeling 11 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Shinjo Ophthalmologic Institute
🇯🇵Miyazaki, Japan
Shinjo Ophthalmologic Institute🇯🇵Miyazaki, Japan